Cargando…
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
BACKGROUND: More alternatives have become available for the diagnosis and treatment of cancer in low- and middle-income countries. Because of increasing demands, governments are now facing a problem of limited affordability and availability of essential cancer medicines. Yet, precise information abo...
Autores principales: | Moye-Holz, Daniela, Ewen, Margaret, Dreser, Anahi, Bautista-Arredondo, Sergio, Soria-Saucedo, Rene, van Dijk, Jitse P., Reijneveld, Sijmen A., Hogerzeil, Hans V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222474/ https://www.ncbi.nlm.nih.gov/pubmed/32410676 http://dx.doi.org/10.1186/s12913-020-05167-9 |
Ejemplares similares
-
Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country
por: Moye-Holz, Daniela, et al.
Publicado: (2017) -
Access to innovative cancer medicines in a middle-income country - the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2018) -
Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019) -
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America
por: Moye-Holz, Daniela, et al.
Publicado: (2021) -
Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)